Oculis secures FDA Breakthrough Therapy Designation for Privosegtor in optic neuritis

Nanjing Delova Biotech reports positive Phase 3 trial results for QP-6211 for postoperative pain

MetaVia reports positive results from Phase 1 clinical trial in obesity

RedHill advances RHB-102 across GI indications

Halozyme licenses ENHANZE to Skye Bioscience for nimacimab obesity programme

Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China

BioInvent reports encouraging Phase 2a data for BI-1808 plus pembrolizumab in recurrent ovarian cancer

FDA grants priority review for Sanofi's Tzield in young children with stage 2 type 1 diabetes

GSK secures China approval for Nucala in COPD

Insilico Medicine signs multi-year research and development collaboration with Servier

WuXi Biologics achieves ISO 20400 Sustainable Procurement certification

ChemPartner updates its visual identity and digital experience

Delcath publishes Phase 3 FOCUS subgroup data supporting HEPZATO in metastatic uveal melanoma

Axsome Therapeutics secures FDA priority review for AXS-05 in Alzheimer's disease agitation

Mabwell reports first patient dosed in Phase II clinical trial of anti-IL-11 monoclonal antibody for pathological scarring